全文获取类型
收费全文 | 779篇 |
免费 | 27篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 38篇 |
妇产科学 | 3篇 |
基础医学 | 59篇 |
口腔科学 | 9篇 |
临床医学 | 108篇 |
内科学 | 186篇 |
皮肤病学 | 2篇 |
神经病学 | 5篇 |
特种医学 | 314篇 |
外科学 | 16篇 |
综合类 | 15篇 |
预防医学 | 20篇 |
眼科学 | 3篇 |
药学 | 30篇 |
中国医学 | 1篇 |
肿瘤学 | 18篇 |
出版年
2021年 | 7篇 |
2019年 | 1篇 |
2018年 | 6篇 |
2017年 | 1篇 |
2016年 | 1篇 |
2015年 | 6篇 |
2014年 | 5篇 |
2013年 | 6篇 |
2012年 | 2篇 |
2011年 | 8篇 |
2010年 | 11篇 |
2009年 | 16篇 |
2008年 | 14篇 |
2007年 | 24篇 |
2006年 | 10篇 |
2005年 | 11篇 |
2004年 | 6篇 |
2003年 | 10篇 |
2002年 | 13篇 |
2001年 | 8篇 |
2000年 | 9篇 |
1999年 | 13篇 |
1998年 | 47篇 |
1997年 | 40篇 |
1996年 | 59篇 |
1995年 | 45篇 |
1994年 | 34篇 |
1993年 | 40篇 |
1992年 | 15篇 |
1991年 | 13篇 |
1990年 | 10篇 |
1989年 | 31篇 |
1988年 | 35篇 |
1987年 | 28篇 |
1986年 | 25篇 |
1985年 | 39篇 |
1984年 | 20篇 |
1983年 | 22篇 |
1982年 | 26篇 |
1981年 | 24篇 |
1980年 | 13篇 |
1979年 | 3篇 |
1978年 | 5篇 |
1977年 | 27篇 |
1976年 | 18篇 |
1975年 | 14篇 |
1970年 | 1篇 |
1969年 | 1篇 |
1967年 | 1篇 |
1966年 | 1篇 |
排序方式: 共有828条查询结果,搜索用时 0 毫秒
31.
ER Brown KA Charles SA Hoare RL Rye DI Jodrell RE Aird R Vora U Prabhakar M Nakada RE Corringham M DeWitte C Sturgeon D Propper FR Balkwill JF Smyth 《Annals of oncology》2008,19(7):1340-1346
BACKGROUND: Tumour necrosis factor-alpha (TNF-alpha) is an important regulator of the chronic inflammation contributing to tumour progression. Infliximab, an anti-TNF-alpha monoclonal antibody was investigated in this trial of patients with advanced cancer. The primary objectives were to determine the safety profile and biological response of infliximab in a cancer population. Clinical response was a secondary objective. PATIENTS AND METHODS: Forty-one patients received infliximab at 5 mg/kg (n = 21) or 10 mg/kg (n = 20) i.v. at 0 and 2 weeks and then every 4 weeks. Post-treatment samples were measured for changes in plasma and serum TNF-alpha, CCL2, IL-6 and C-reactive protein (CRP). RESULTS: Infliximab was well tolerated with no dose-limiting toxic effects. At both doses of infliximab, neutralisation of serum TNF-alpha was observed after 1 h while plasma CCL2, IL-6 and serum CRP were decreased 24 and 48 h following infliximab administration. Seven patients experienced disease stablisation (range 10-50+ weeks). There was no evidence of disease acceleration in any patient. CONCLUSIONS: Infliximab treatment was safe and well tolerated in patients with advanced cancer. There was evidence of biological activity with baseline TNF-alpha and CCL2 being correlated with infliximab response. 相似文献
32.
33.
34.
35.
36.
37.
Multispectral analysis of magnetic resonance images 总被引:1,自引:0,他引:1
Magnetic resonance (MR) imaging systems produce spatial distribution estimates of proton density, relaxation time, and flow, in a two dimensional matrix form that is analogous to that of the image data obtained from multispectral imaging satellites. Advanced NASA satellite image processing offers sophisticated multispectral analysis of MR images. Spin echo and inversion recovery pulse sequence images were entered in a digital format compatible with satellite images and accurately registered pixel by pixel. Signatures of each tissue class were automatically determined using both supervised and unsupervised classification. Overall tissue classification was obtained in the form of a theme map. In MR images of the brain, for example, the classes included CSF, gray matter, white matter, subcutaneous fat, muscle, and bone. These methods provide an efficient means of identifying subtle relationships in a multi-image MR study. 相似文献
38.
39.
40.